Advanced ovarian cancer: Three-year results of a 6–8 month, 2-drug cisplatin-containing regimen
- 1 June 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (6) , 631-641
- https://doi.org/10.1016/0277-5379(87)90258-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancerGynecologic Oncology, 1983
- Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1983
- Advanced Ovarian Cancer: A Prospective Randomised Trial of Chlorambucil Versus Combined Cyclophosphamide and Cis-diamminedichloroplatinumAustralian and New Zealand Journal of Medicine, 1982
- CYCLOPHOSPHAMIDE PLUS CIS-PLATINUM IN COMBINATION - TREATMENT PROGRAM FOR STAGE-III OR STAGE-IV OVARIAN-CARCINOMA1982
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- On distribution-free tests for equality of survival distributionsBiometrika, 1977
- The Enhanced Therapeutic Effect of cis-Platinum (II) Diamminodichloride against L1210 Leukemia when Combined with Cyclophosphamide or 1,2-bis(3,5-Dioxopiperazine-1-yl)propane or Several other Antitumor AgentsChemotherapy, 1973